PT-141 (Bremelanotide): What It Does, Who It's For and What the Trials Show

Desire used to show up on its own. Now it doesn't, or it shows up and your body doesn't follow. You love your partner, you're not unhappy, and you can't explain why the interest faded. Maybe you've been told it's stress, age or "just a phase," and now you're reading about a peptide called PT-141.

The change felt real. The explanation never fully did.

PT-141, also called bremelanotide, is a peptide that acts on melanocortin receptors in the brain to increase sexual desire and arousal. It's FDA-approved as Vyleesi, an injection for premenopausal women with low sexual desire that causes distress. In men it's used off-label, most often when blood-flow medications haven't worked.

When Low Desire Gets Treated as a Side Note

Low desire rarely gets its own appointment. It gets folded into whatever else you mention:

• Low libido gets "it's stress."
• Erection problems get a pill.
• Fatigue gets more coffee.
• Weight gain gets "eat less."
• Poor sleep gets melatonin.
• Feeling flat gets an antidepressant, which can lower desire further.

What if they're connected?

Desire depends on hormones, blood flow, energy, sleep and mood all working at once. This usually comes down to how care is set up. A short visit is built to rule out disease, so each symptom gets its own fix and nobody looks at how they fit together.

We're Not Here to Convince You That You Need PT-141

We're not here to convince you that you need PT-141. We're here to figure out why you don't feel like yourself anymore.

Sometimes PT-141 is a good fit. Often the change in desire is coming from somewhere else:

• Sex hormones, including testosterone, estrogen and progesterone
• Thyroid function
• Insulin and metabolic health
• Inflammation
• Sleep and stress
• Nutrient status, such as iron and vitamin D

"Your labs look normal."

Okay, but which labs?

• A routine panel often skips sex hormones entirely.
• Reference ranges are population averages, so in range is a starting point.

Normal is an average. You are not an average.

At RHM we read more than 160 biomarkers across those systems as one picture before choosing a treatment. For women, that work happens through our sexual health care. For men, it happens through our erectile dysfunction and libido clinic.

Desire Runs on a Circuit, and PT-141 Works on One Part of It

PT-141 turns up the desire signal in the brain. How well that works depends on the rest of the circuit: your hormones, your blood flow and how much energy you have left at the end of the day.

You may have been told low libido is "all in your head" or all about hormones. Thinking of desire as a circuit explains why both are partly true.

1. The brain signal

Desire starts in the brain. PT-141 is a synthetic version of a natural hormone called alpha-melanocyte-stimulating hormone, and it binds strongly to the melanocortin-4 receptor, which is involved in sexual response (Dhillon and Keam, Drugs, 2019). This is the part PT-141 works on.

2. The hormones that prime it

Testosterone, estrogen and progesterone set how responsive that circuit is. Thyroid hormone and prolactin affect it too. When these shift, as they do in perimenopause or with falling testosterone, the signal has less to work with.

3. Blood flow and tissue

Arousal needs healthy blood vessels and responsive tissue. Insulin resistance, high blood pressure and low estrogen in vaginal tissue can all get in the way, even when desire is there.

4. Energy, sleep and mood

Exhaustion, poor sleep, stress, depression and some medications can turn desire down at the source. No peptide fully overrides a body that's running on empty.

Each part belongs to a different system. That's why we test before we prescribe.

What the PT-141 Trials Actually Show

You may have seen PT-141 described as a "female Viagra." The trial data tells a more useful story.

The two Phase 3 RECONNECT trials enrolled 1,267 premenopausal women with low sexual desire, average age 39, for 24 weeks (Kingsberg et al., Obstetrics & Gynecology, 2019):

• Desire improved more than with placebo, by 0.30 and 0.42 points on the desire scale used in the trials.
• Distress about low desire went down more than with placebo.
• Nausea was common: 40% of women on bremelanotide had it, compared with 1.3% on placebo. Most cases were mild to moderate, and 8.1% stopped treatment because of it.

The improvement was measurable but modest. For some women it makes a meaningful difference. For others, the cause of low desire sits elsewhere in the circuit, and that's where treatment does more good.

PT-141 for Women

You may have been told that low desire after kids, during perimenopause or in a long relationship is just how it goes. Sometimes it's more than that, and it's treatable.

Vyleesi is approved for premenopausal women with acquired, generalized low desire that causes distress. The FDA label states it isn't approved for postmenopausal women or for men, and it isn't meant to enhance sexual performance (Vyleesi prescribing information, DailyMed).

It isn't the only option. Flibanserin (Addyi) is a daily pill approved for the same group of premenopausal women (Gelman and Atrio, Therapeutic Advances in Chronic Disease, 2017). After menopause, the strongest evidence points to a different treatment:

• An international consensus statement found that testosterone therapy is supported for postmenopausal women diagnosed with low sexual desire.
• It recommends that diagnosis come after a full assessment of physical, psychological and relationship factors (Davis et al., Journal of Clinical Endocrinology & Metabolism, 2019).

If your desire changed alongside hot flashes, broken sleep or irregular cycles, our guide to the signs you need hormone replacement therapy may explain more of the picture.

PT-141 for Men

You may have been offered a stronger dose of the same pill when the first one stopped working. PT-141 works through a different pathway, which is why it gets attention in men's health.

Erection pills such as sildenafil work on blood flow. PT-141 works on the brain's desire and arousal signals. In a randomized trial of 342 men whose erectile dysfunction hadn't responded to sildenafil, 33.5% had a positive response with bremelanotide, compared with 8.5% on placebo (Safarinejad and Hosseini, Journal of Urology, 2008).

That's encouraging, but it's one trial, and PT-141 isn't FDA-approved for men. Low testosterone is a common reason for low desire in men, and the cause decides the treatment:

• If testosterone is low, treating it may bring desire back on its own. Our hormone therapy for men starts with that question.
• If blood flow is the issue, metabolic health and vascular care come first.
• If desire and arousal signals are the issue, PT-141 may help, alone or alongside other treatment.

How PT-141 Is Used

You may have pictured a daily shot or a pill you take every morning. PT-141 works differently, and knowing how it's used helps set realistic expectations.

• As needed, not daily. The approved form is a small autoinjector used under the skin of the abdomen or thigh, at least 45 minutes before sex.
• With limits on frequency. The label limits how often it can be used, because doses close together add to the blood pressure effect and raise the chance of skin darkening.
• With a check-in point. The label advises stopping after 8 weeks if there's no improvement, so it's easy to tell whether it's working for you.

Your physician decides the form, the amount and how often it fits your health, so we don't list doses here.

PT-141 Side Effects and Who Should Avoid It

You may have read that peptides are "natural," so they're safe. PT-141 is well studied, and like any medication it has known effects:

• Nausea is the most common side effect, especially with the first doses.
• Flushing and headache were the other common effects in trials.
• Blood pressure rises temporarily after a dose. Vyleesi is contraindicated in people with uncontrolled high blood pressure or known heart disease.
• Skin darkening in patches on the face, gums or breasts was reported in about 1% of trial patients.
• Naltrexone: PT-141 can lower the effect of oral naltrexone, so it shouldn't be combined with naltrexone used to treat alcohol or opioid addiction.

These come from the FDA label. They're the reason a physician should check your blood pressure, heart health and medications before you start.

Prescribed PT-141 and "Research" Peptides

You can find PT-141 nasal sprays and vials sold online as "research peptides." They're cheap and easy to order, so it's worth asking a few questions first:

• Who is prescribing it, and did anyone check your blood pressure and heart health?
• Where is it coming from, and what quality standards apply to what's in the vial?
• Who is watching how your body responds, and what happens if it doesn't help?
• Did anyone ask why your desire changed in the first place?

The FDA-approved form is an injection prescribed by a clinician. Products labeled "not for human use" aren't made or tested for people.

Curious how PT-141 fits with other peptides? Our peptide therapy for men page explains how we choose for men. Our peptide therapy for women page does the same for women.

Dr. Rand Insight:

How We Approach Low Desire at RHM

You may have tried to piece this together yourself, one symptom and one search at a time. Our process puts the pieces in one place:

1. A conversation first. We ask what changed, when it changed and what else changed around the same time: sleep, weight, stress, cycles, medications.
2. Labs across systems. Sex hormones, thyroid, prolactin, metabolic markers, iron and vitamin D, read together.
3. A plan built on the cause. That might be hormone therapy, metabolic work, sleep, a medication change, PT-141, or a combination.
4. Follow-up and adjustment. We check how you respond, including blood pressure if PT-141 is part of the plan, and change course if something isn't working.

That way, if PT-141 is part of your plan, it's there because your results point to it.

When PT-141 Isn't the Right First Step

You came here for an answer, and sometimes the answer is that PT-141 isn't where to start. We'd rather tell you that than prescribe it by default.

• Pain or dryness during sex usually points to tissue changes, such as low estrogen in vaginal tissue, which local treatment addresses.
• A medication that flattened desire, such as some antidepressants, may need a conversation with the prescriber.
• Low testosterone, thyroid problems or poor sleep are worth treating first, since fixing them can bring desire back.
• Relationship strain or past trauma deserves support of its own, and a peptide won't replace it.

We work alongside your gynecologist, urologist, therapist or other specialists when those questions come up.

Frequently Asked Questions

What is PT-141 used for?

PT-141 is used to increase sexual desire and arousal. As Vyleesi, it's FDA-approved for premenopausal women with low desire that causes distress. In men, it's used off-label for low desire and erectile problems.

Is PT-141 FDA-approved?

Yes, for one use. Bremelanotide is FDA-approved as Vyleesi for premenopausal women with hypoactive sexual desire disorder. It isn't approved for men or postmenopausal women.

How is PT-141 different from Viagra?

Viagra and similar pills increase blood flow to the penis. PT-141 acts on desire and arousal pathways in the brain, so it can help some people who don't respond to blood-flow medications.

What are the side effects of PT-141?

Nausea, flushing and headache are the most common. It can raise blood pressure temporarily and occasionally causes skin darkening, so a physician should check your blood pressure and heart health first.

Can men use PT-141?

Men can use it off-label with a prescription. A randomized trial in men who didn't respond to sildenafil found a higher response rate than placebo, but it isn't FDA-approved for men.

Are PT-141 nasal sprays safe?

The FDA-approved form is an injection. Nasal sprays sold online as research peptides aren't FDA-approved, and their contents and quality aren't verified.

Find Out Why You Don't Feel Like Yourself

If you're ready to stop guessing, understand what may be driving these changes and take back control of your health, we're ready to help. If you're ready to pursue care and see what your next steps could look like, book a VIP call with our team.

Book a VIP Call